Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 8, 2006, Pages 879-889

  Petrou, S ^a   Trinder, J ^b   Brocklehurst, P ^a   Smith, L ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

^c East Somerset Research Consortium   (United Kingdom)

Author keywords

Cost effectiveness; Economic evaluation; First trimester; Miscarriage

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DATA ANALYSIS; ECONOMIC EVALUATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GYNECOLOGIC INFECTION; HEALTH SERVICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MISSED ABORTION; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; SOCIAL WORK; SPONTANEOUS ABORTION; UNITED KINGDOM;

ABORTION, SPONTANEOUS; COST-BENEFIT ANALYSIS; ENGLAND; FEMALE; HEALTH CARE COSTS; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE;

EID: 33746172638     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.00998.x     Document Type: Article

References (36)

1. Regan L, Braude PB, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989;299:541-5.
2. Jurkovic D. Modern management of miscarriage: is there a place for non-surgical treatment? Ultrasound Obstet Gynecol 1998;11:161-3.
3. Cahill DJ. Managing spontaneous first trimester miscarriage. BMJ 2001;322:1315-16.
4. Ankum WM, Wieringa-de Waard M, Bindels PJE. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ 2001;322: 1343-6.
5. Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet 1995;345:84-6.
6. Chipchase J, James D. Randomised trial of expectant versus surgical management of spontaneous miscarriage. Br J Obstet Gynaecol 1997;104:840-1.
7. Wieringa-de Waard M, Vos J, Bonsel GJ, Bindels PJ, Ankum WM. Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. Hum Reprod 2002; 17:2445-50.
8. De Jonge ET, Makin JD, Manefeldt E, De Wet GH, Pattinson RC. Randomised clinical trial of medical evacuation and surgical curettage for incomplete miscarriage. BMJ 1995;311:662.
9. Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol 1997;89:768-72.
10. Johnson N, Priestnall M, Marsay T, Ballard P, Watters J. A randomised trial evaluating pain and bleeding after first trimester miscarriage treated surgically or medically. Eur J Obstet Gynecol Reprod Biol 1997;72:213-15.
11. Chung TK, Lee DT, Cheung LP, Haines CJ, Chang AM. Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril 1999;71:1054-9.
12. Demetroulis C, Saridogan E, Kunde D, Naftalin A. A prospective randomised control trial comparing medical and surgical treatment for early pregnancy failure. Hum Reprod 2001;16:365-9.
13. Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. Br J Obstet Gynaecol 1999;106:804-7.
14. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical or surgical? Results of a randomised controlled trial (the MIST trial). BMJ 2006;332:1235-40.
15. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford, UK: Oxford University Press, 1997.
16. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313:275-83.
17. Allen C, Beecham J. Costing services: ideals and reality. In: Netten A, Beecham J, editors. Costing Community Care: Theory and Practice. Aldershot, UK: Ashgate Publishing Ltd; 1993. p. 25-42.
18. Henderson J, Bricker L, Roberts T, Mugford M, Garcia J, Neilson J. British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests. Ultrasound Obstet Gynecol 2002;20:154-62.
19. Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med 2003;13:205-18.
20. Netten A, Curtis L. Unit Costs of Health and Social Care. Canterbury, UK: Personal Social Services Research Unit, University of Kent, 2002.
21. Office of National Statistics. New Earnings Survey. London: ONS, 2002.
22. Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ 2000;9:623-30.
23. Briggs AH, O'Brien BJ. The death of cost-minimization analysis. Health Econ 2001;10:179-84.
24. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53:419-34.
25. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000;19:3219-36.
26. Black WC. The cost-effectiveness plane: a graphical representation of cost-effectiveness. Med Decis Making 1990;10:212-15.
27. Briggs A, Sculpher M. Sensitivity analysis in economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1995;4:355-72.
28. Petrou S, Murray L, Cooper P, Davidson LL. The accuracy of self-reported health care resource utilisation in health economic studies. Int J Technol Assess Health Care 2002;18:705-10.
29. Drummond MF. Cost-effectiveness guidelines for reimbursement of pharmaceutical: is economic evaluation ready for its enhanced status? Health Econ 1992;1:85-92.
30. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
31. National Institute for Clinical Excellence. Technical Guidance for Manufacturers and Sponsors on Making a Submission to Technology Appraisal. London: National Institute for Clinical Excellence, 2001.
32. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
33. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
34. Jenkinson C, Layte R, Wright L, Coulter A. The UK SF-36: An Analysis and Interpretation Manual. Oxford, UK: Health Services Research Unit, University of Oxford, 1996.
35. O'Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference. Med Decis Making 1994;14: 289-97.
36. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in-vitro fertilisation. Soc Sci Med 1999;48:535-46.